Eli Lilly and Company
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2007 | $5.15B | $4.07B | $1.08B | $-282.0M |
| FY2008 | $7.30B | $6.35B | $947.2M | $255.3M |
| FY2009 | $4.34B | $3.57B | $765.0M | $368.5M |
| FY2010 | $6.86B | $6.16B | $694.3M | $231.0M |
| FY2011 | $7.23B | $6.56B | $672.0M | $147.4M |
| FY2012 | $5.30B | $4.40B | $905.4M | $141.5M |
| FY2013 | $5.74B | $4.72B | $1.01B | $144.9M |
| FY2014 | $4.46B | $3.30B | $1.16B | $156.0M |
| FY2015 | $2.96B | $1.90B | $1.07B | $217.8M |
| FY2016 | $4.85B | $3.81B | $1.04B | $255.3M |
| FY2017 | $5.62B | $4.54B | $1.08B | $281.3M |
| FY2018 | $5.52B | $4.31B | $1.21B | $279.5M |
| FY2019 | $4.84B | $3.80B | $1.03B | $312.4M |
| FY2020 | $6.50B | $5.11B | $1.39B | $308.1M |
| FY2021 | $7.37B | $6.06B | $1.31B | $342.8M |
| FY2022 | $7.59B | $5.73B | $1.85B | $371.1M |
| FY2023 | $4.24B | $792.0M | $3.45B | $629.0M |
| FY2024 | $8.82B | $3.76B | $5.06B | $646.0M |
| FY2025 | $16.81B | $8.97B | $7.84B | $626.0M |